Navigation Links
Full Agenda Announced for CBI's Commercialization and Market Access Congress (CMAC 2010)
Date:9/30/2010

WOBURN, Mass., Sept. 30 /PRNewswire/ -- The Center for Business Intelligence (CBI) recently announced the full agenda for their life sciences Commercialization and Market Access Congress (CMAC 2010). CBI, a renowned leader in the commercialization arena, has combined four of their most respected events - Product Launch, Product Pricing, Early-Stage Commercialization and Specialty Drug Commercialization - into one comprehensive agenda with extensive coverage of the evolving dynamics impacting market access and commercialization. The Congress takes place December 8-9, 2010 in Orlando, FL.

CMAC 2010 combines both a strategic view of current events impacting commercialization with targeted breakouts and tracks, addressing models for commercialization that respond to the new economic landscape while accounting for the changing relationship between patients, physicians and payers. A keynote panel discussion on "Changes in the Market Access Landscape" will be a highlight at this timely event.

CMAC's speaker faculty includes more than 30 of the country's leading experts from the most innovative biotechnology and medical device companies to the most established pharmaceutical companies including Abbott, AstraZeneca, Bayer HealthCare Pharmaceuticals, Cephalon, Daiichi Sankyo, Endo Pharmaceuticals, Medtronic, Mannkind Corporation, Merck, Pfizer, Schering-Plough, Shire, Talecris Biotherapeutics and many more.  

CMAC 2010 is the industry's only opportunity to participate in an executive-level exchange addressing the overarching product development and launch environment, as well as tactical approaches for pricing, reimbursement, product launch, commercial strategy, branding, managed care and HEOR. For more information on the conference or to view the entire agenda, please visit http://www.cmac2010.com.  

About CBI:

A subsidiary of Advanstar Communications, The Center for Business Intelligence (CBI) is dedicated to developing market-driven, unbiased conferences in the pharmaceutical, biotechnology and medical device industries. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit http://www.cbinet.com.  

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Center for Business Intelligence
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
2. TechConnect World Publishes Conference Agenda Featuring More than 2,700 Presentations Addressing Nano, Bio and Clean Technologies
3. American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia
4. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
5. CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
6. 'Biopolymers Symposium 2010' Agenda Announced
7. 2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expos 14-Year History
8. 2008 R&D Innovator of the Year & Scientist of the Year Finalists Announced
9. First Annual Arizona Biotech Day Announced for October 23rd 2008
10. Presenters Announced For MichBio Expos Emerging Business Showcase
11. New Young Investigator Grants for Probiotics Research Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):